Role of Oxytocin in Telling and Detecting Lies

NCT ID: NCT02361177

Last Updated: 2016-06-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

EARLY_PHASE1

Study Classification

INTERVENTIONAL

Study Start Date

2016-01-31

Study Completion Date

2016-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators are interested in the impact of intranasal oxytocin in unethical behavior.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objective of this project is to further explore the role of oxytocin in moral judgment and ethical behavior. Oxytocin is a peptide hormone produced in a variety of hypothalamic neurons. It is released into the brain or brought into general circulation through sensory stimuli in a pulsatile fashion. In social psychology research, oxytocin is hypothesized to coordinate both the causes and effects of positive social interactions in a biofeedback loop.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dyssocial Behavior

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

oxytocin

Intranasal 24 IU oxytocin self-administration.

Group Type EXPERIMENTAL

Oxytocin

Intervention Type DRUG

Intranasal oxytocin is hypothesized to amplify the influence of social norms on unethical behavior.

placebo

Intranasal placebo. 125 mg of 0.5% cholorobutanol to 50 ml saline, with approximately 5 pH. The solution will then be sterilized using a 0.22 micron filter.

Group Type PLACEBO_COMPARATOR

Oxytocin

Intervention Type DRUG

Intranasal oxytocin is hypothesized to amplify the influence of social norms on unethical behavior.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Oxytocin

Intranasal oxytocin is hypothesized to amplify the influence of social norms on unethical behavior.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

syntocinon

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male

Exclusion Criteria

* \_\_\_\_\_ \_\_\_\_\_BP \> 130/85, HRT \> 95 (can be included at discretion of study physician/designee)

* \_\_\_\_\_History of seizures
* \_\_\_\_\_Neurological Disorder
* \_\_\_\_\_Current psychiatric disorder
* \_\_\_\_\_Previous psychiatric disorder (can be included at discretion of PI)
* Date last episode (if \> 1 year, include; if \<1 year, at discretion of PI)
* \_\_\_\_\_Current use of psychoactive drugs
* \_\_\_\_\_Previous use of psychoactive drugs (can be included at discretion of PI) \_\_\_\_\_Date last medicated\_\_\_\_\_ \_\_\_\_\_Type of medication\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
* \_\_\_\_\_Current use of anticoagulants
* \_\_\_\_\_Current use of corticosteroids
* \_\_\_\_\_Previous head trauma (can be included at discretion of PI)
* \_\_\_\_\_Alcoholism or substance abuse
* \_\_\_\_\_Carcinoma of the breast or prostate
* \_\_\_\_\_Renal or Hepatic diseases
* \_\_\_\_\_Chronic lung diseases
* \_\_\_\_\_Cancer
* \_\_\_\_\_Liver problems
* \_\_\_\_\_Hypertension/Cardiac diseases
* \_\_\_\_\_Cardiovascular Disease
* \_\_\_\_\_Nephritis
* \_\_\_\_\_Diabetes (use of insulin) /Obesity
* \_\_\_\_\_Endocrine disease or malignancy
* \_\_\_\_\_Asthma (can be included as discretion of study physician/designee, if episodes are infrequent, nonmedicated, and no active problems at time of study)
* Medication
* Frequency of episodes\_\_\_\_ \_\_\_\_\_Date of last episode\_\_\_\_\_
* \_\_\_\_\_Migraines(can be included as discretion of study physician/designee, if episodes are infrequent, nonmedicated, and no active problems at time of study)
* Medication \_\_\_\_\_Frequency of migraines\_\_\_\_\_ \_\_\_\_\_Date of last migraine\_\_\_\_\_
* \_\_\_\_\_High levels of physical contact with women or children
Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Harvard University

OTHER

Sponsor Role collaborator

University of Texas at Austin

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Robert A Josephs, PhD

Role: PRINCIPAL_INVESTIGATOR

utaustin

References

Explore related publications, articles, or registry entries linked to this study.

Kosfeld M, Heinrichs M, Zak PJ, Fischbacher U, Fehr E. Oxytocin increases trust in humans. Nature. 2005 Jun 2;435(7042):673-6. doi: 10.1038/nature03701.

Reference Type RESULT
PMID: 15931222 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2013-11-0033

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Oxytocin and Social Cognition
NCT01606462 COMPLETED PHASE1
Dog Presence and Oxytocin on Trust Towards Therapists
NCT06248710 RECRUITING PHASE2/PHASE3
Neuropeptides and Social Behavior
NCT01680718 COMPLETED EARLY_PHASE1